世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ゲノムバイオマーカーの世界市場に関する洞察と2028年までの予測


Global Genomic Biomarkers Market Insights and Forecast to 2028

市場の分析と洞察。ゲノムバイオマーカーの世界市場 ゲノムバイオマーカーの世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率(%)で推移... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年2月11日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場の分析と洞察。ゲノムバイオマーカーの世界市場
ゲノムバイオマーカーの世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率(%)で推移しています。
この健康危機による経済変化を十分に考慮し、2021年にゲノムバイオマーカー世界市場の%を占めたオンコロジーは、2028年には百万米ドルの価値を持ち、COVID-19後の期間に改訂された%のCAGRで成長すると予測されます。一方、診断および研究機関セグメントは、この予測期間を通して%CAGRに変更されています。
中国のゲノムバイオマーカー市場規模は2021年に百万米ドル、北米と欧州のゲノムバイオマーカーはそれぞれ百万米ドルと百万米ドルです。北米の割合は2021年に%、中国とヨーロッパはそれぞれ%と%であり、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%となります。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%である。欧州のゲノムバイオマーカーについては、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
本レポートは、業界標準の分析精度と高いデータ整合性により、世界のゲノムバイオマーカー市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つよう、優れた試みを行っています。本レポートの購入者は、世界のゲノムバイオマーカー市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界のゲノムバイオマーカー市場で永続的な成功を収めるための有効なツールになるものと思われます。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界のゲノムバイオマーカー市場を詳細に調査するため、独自の業界最高水準の調査分析アプローチを採用しています。

世界のゲノムバイオマーカーの範囲と市場規模
ゲノムバイオマーカー市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界のゲノムバイオマーカー市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。

タイプ別セグメント
オンコロジー
循環器系疾患
神経系疾患
その他
用途別セグメント
診断・研究機関
病院
その他
会社別
サーモフィッシャーサイエンティフィック
ロシュ
エポディア
ミリアドジェネティクス
ユーロフィンズサイエンティフィック
QIAGEN
バイオ・ラッド・ラボラトリーズ
ジェノミックヘルス
リキッドゲノミクス
エピゲノミクス
AROSアプライド・バイオテクノロジー
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oncology
1.2.3 Cardiovascular Diseases
1.2.4 Neurological Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genomic Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic and Research Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarkers Market Perspective (2017-2028)
2.2 Genomic Biomarkers Growth Trends by Region
2.2.1 Genomic Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genomic Biomarkers Historic Market Size by Region (2017-2022)
2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2023-2028)
2.3 Genomic Biomarkers Market Dynamics
2.3.1 Genomic Biomarkers Industry Trends
2.3.2 Genomic Biomarkers Market Drivers
2.3.3 Genomic Biomarkers Market Challenges
2.3.4 Genomic Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarkers Players by Revenue
3.1.1 Global Top Genomic Biomarkers Players by Revenue (2017-2022)
3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2017-2022)
3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomic Biomarkers Revenue
3.4 Global Genomic Biomarkers Market Concentration Ratio
3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2021
3.5 Genomic Biomarkers Key Players Head office and Area Served
3.6 Key Players Genomic Biomarkers Product Solution and Service
3.7 Date of Enter into Genomic Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarkers Breakdown Data by Type
4.1 Global Genomic Biomarkers Historic Market Size by Type (2017-2022)
4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028)
5 Genomic Biomarkers Breakdown Data by Application
5.1 Global Genomic Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomic Biomarkers Market Size (2017-2028)
6.2 North America Genomic Biomarkers Market Size by Type
6.2.1 North America Genomic Biomarkers Market Size by Type (2017-2022)
6.2.2 North America Genomic Biomarkers Market Size by Type (2023-2028)
6.2.3 North America Genomic Biomarkers Market Share by Type (2017-2028)
6.3 North America Genomic Biomarkers Market Size by Application
6.3.1 North America Genomic Biomarkers Market Size by Application (2017-2022)
6.3.2 North America Genomic Biomarkers Market Size by Application (2023-2028)
6.3.3 North America Genomic Biomarkers Market Share by Application (2017-2028)
6.4 North America Genomic Biomarkers Market Size by Country
6.4.1 North America Genomic Biomarkers Market Size by Country (2017-2022)
6.4.2 North America Genomic Biomarkers Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Genomic Biomarkers Market Size (2017-2028)
7.2 Europe Genomic Biomarkers Market Size by Type
7.2.1 Europe Genomic Biomarkers Market Size by Type (2017-2022)
7.2.2 Europe Genomic Biomarkers Market Size by Type (2023-2028)
7.2.3 Europe Genomic Biomarkers Market Share by Type (2017-2028)
7.3 Europe Genomic Biomarkers Market Size by Application
7.3.1 Europe Genomic Biomarkers Market Size by Application (2017-2022)
7.3.2 Europe Genomic Biomarkers Market Size by Application (2023-2028)
7.3.3 Europe Genomic Biomarkers Market Share by Application (2017-2028)
7.4 Europe Genomic Biomarkers Market Size by Country
7.4.1 Europe Genomic Biomarkers Market Size by Country (2017-2022)
7.4.2 Europe Genomic Biomarkers Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarkers Market Size (2017-2028)
8.2 Asia-Pacific Genomic Biomarkers Market Size by Type
8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Genomic Biomarkers Market Share by Type (2017-2028)
8.3 Asia-Pacific Genomic Biomarkers Market Size by Application
8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Genomic Biomarkers Market Share by Application (2017-2028)
8.4 Asia-Pacific Genomic Biomarkers Market Size by Region
8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genomic Biomarkers Market Size (2017-2028)
9.2 Latin America Genomic Biomarkers Market Size by Type
9.2.1 Latin America Genomic Biomarkers Market Size by Type (2017-2022)
9.2.2 Latin America Genomic Biomarkers Market Size by Type (2023-2028)
9.2.3 Latin America Genomic Biomarkers Market Share by Type (2017-2028)
9.3 Latin America Genomic Biomarkers Market Size by Application
9.3.1 Latin America Genomic Biomarkers Market Size by Application (2017-2022)
9.3.2 Latin America Genomic Biomarkers Market Size by Application (2023-2028)
9.3.3 Latin America Genomic Biomarkers Market Share by Application (2017-2028)
9.4 Latin America Genomic Biomarkers Market Size by Country
9.4.1 Latin America Genomic Biomarkers Market Size by Country (2017-2022)
9.4.2 Latin America Genomic Biomarkers Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarkers Market Size (2017-2028)
10.2 Middle East & Africa Genomic Biomarkers Market Size by Type
10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Genomic Biomarkers Market Share by Type (2017-2028)
10.3 Middle East & Africa Genomic Biomarkers Market Size by Application
10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Genomic Biomarkers Market Share by Application (2017-2028)
10.4 Middle East & Africa Genomic Biomarkers Market Size by Country
10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Genomic Biomarkers Introduction
11.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Aepodia
11.3.1 Aepodia Company Details
11.3.2 Aepodia Business Overview
11.3.3 Aepodia Genomic Biomarkers Introduction
11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022)
11.3.5 Aepodia Recent Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Genomic Biomarkers Introduction
11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022)
11.4.5 Myriad Genetics Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Genomic Biomarkers Introduction
11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022)
11.5.5 Eurofins Scientific Recent Developments
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarkers Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022)
11.6.5 QIAGEN Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Genomic Health
11.8.1 Genomic Health Company Details
11.8.2 Genomic Health Business Overview
11.8.3 Genomic Health Genomic Biomarkers Introduction
11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022)
11.8.5 Genomic Health Recent Developments
11.9 Liquid Genomics
11.9.1 Liquid Genomics Company Details
11.9.2 Liquid Genomics Business Overview
11.9.3 Liquid Genomics Genomic Biomarkers Introduction
11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022)
11.9.5 Liquid Genomics Recent Developments
11.10 Epigenomics
11.10.1 Epigenomics Company Details
11.10.2 Epigenomics Business Overview
11.10.3 Epigenomics Genomic Biomarkers Introduction
11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022)
11.10.5 Epigenomics Recent Developments
11.11 AROS Applied Biotechnology
11.11.1 AROS Applied Biotechnology Company Details
11.11.2 AROS Applied Biotechnology Business Overview
11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022)
11.11.5 AROS Applied Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Genomic Biomarkers Market
The global Genomic Biomarkers market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oncology accounting for % of the Genomic Biomarkers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Diagnostic and Research Laboratories segment is altered to an % CAGR throughout this forecast period.
China Genomic Biomarkers market size is valued at US$ million in 2021, while the North America and Europe Genomic Biomarkers are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Genomic Biomarkers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomic Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomic Biomarkers market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomic Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomic Biomarkers market.

Global Genomic Biomarkers Scope and Market Size
Genomic Biomarkers market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Genomic Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Oncology
Cardiovascular Diseases
Neurological Diseases
Others
Segment by Application
Diagnostic and Research Laboratories
Hospitals
Others
By Company
Thermo Fisher Scientific
Roche
Aepodia
Myriad Genetics
Eurofins Scientific
QIAGEN
Bio-Rad Laboratories
Genomic Health
Liquid Genomics
Epigenomics
AROS Applied Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oncology
1.2.3 Cardiovascular Diseases
1.2.4 Neurological Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genomic Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic and Research Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarkers Market Perspective (2017-2028)
2.2 Genomic Biomarkers Growth Trends by Region
2.2.1 Genomic Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genomic Biomarkers Historic Market Size by Region (2017-2022)
2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2023-2028)
2.3 Genomic Biomarkers Market Dynamics
2.3.1 Genomic Biomarkers Industry Trends
2.3.2 Genomic Biomarkers Market Drivers
2.3.3 Genomic Biomarkers Market Challenges
2.3.4 Genomic Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarkers Players by Revenue
3.1.1 Global Top Genomic Biomarkers Players by Revenue (2017-2022)
3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2017-2022)
3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomic Biomarkers Revenue
3.4 Global Genomic Biomarkers Market Concentration Ratio
3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2021
3.5 Genomic Biomarkers Key Players Head office and Area Served
3.6 Key Players Genomic Biomarkers Product Solution and Service
3.7 Date of Enter into Genomic Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarkers Breakdown Data by Type
4.1 Global Genomic Biomarkers Historic Market Size by Type (2017-2022)
4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028)
5 Genomic Biomarkers Breakdown Data by Application
5.1 Global Genomic Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomic Biomarkers Market Size (2017-2028)
6.2 North America Genomic Biomarkers Market Size by Type
6.2.1 North America Genomic Biomarkers Market Size by Type (2017-2022)
6.2.2 North America Genomic Biomarkers Market Size by Type (2023-2028)
6.2.3 North America Genomic Biomarkers Market Share by Type (2017-2028)
6.3 North America Genomic Biomarkers Market Size by Application
6.3.1 North America Genomic Biomarkers Market Size by Application (2017-2022)
6.3.2 North America Genomic Biomarkers Market Size by Application (2023-2028)
6.3.3 North America Genomic Biomarkers Market Share by Application (2017-2028)
6.4 North America Genomic Biomarkers Market Size by Country
6.4.1 North America Genomic Biomarkers Market Size by Country (2017-2022)
6.4.2 North America Genomic Biomarkers Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Genomic Biomarkers Market Size (2017-2028)
7.2 Europe Genomic Biomarkers Market Size by Type
7.2.1 Europe Genomic Biomarkers Market Size by Type (2017-2022)
7.2.2 Europe Genomic Biomarkers Market Size by Type (2023-2028)
7.2.3 Europe Genomic Biomarkers Market Share by Type (2017-2028)
7.3 Europe Genomic Biomarkers Market Size by Application
7.3.1 Europe Genomic Biomarkers Market Size by Application (2017-2022)
7.3.2 Europe Genomic Biomarkers Market Size by Application (2023-2028)
7.3.3 Europe Genomic Biomarkers Market Share by Application (2017-2028)
7.4 Europe Genomic Biomarkers Market Size by Country
7.4.1 Europe Genomic Biomarkers Market Size by Country (2017-2022)
7.4.2 Europe Genomic Biomarkers Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarkers Market Size (2017-2028)
8.2 Asia-Pacific Genomic Biomarkers Market Size by Type
8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Genomic Biomarkers Market Share by Type (2017-2028)
8.3 Asia-Pacific Genomic Biomarkers Market Size by Application
8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Genomic Biomarkers Market Share by Application (2017-2028)
8.4 Asia-Pacific Genomic Biomarkers Market Size by Region
8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genomic Biomarkers Market Size (2017-2028)
9.2 Latin America Genomic Biomarkers Market Size by Type
9.2.1 Latin America Genomic Biomarkers Market Size by Type (2017-2022)
9.2.2 Latin America Genomic Biomarkers Market Size by Type (2023-2028)
9.2.3 Latin America Genomic Biomarkers Market Share by Type (2017-2028)
9.3 Latin America Genomic Biomarkers Market Size by Application
9.3.1 Latin America Genomic Biomarkers Market Size by Application (2017-2022)
9.3.2 Latin America Genomic Biomarkers Market Size by Application (2023-2028)
9.3.3 Latin America Genomic Biomarkers Market Share by Application (2017-2028)
9.4 Latin America Genomic Biomarkers Market Size by Country
9.4.1 Latin America Genomic Biomarkers Market Size by Country (2017-2022)
9.4.2 Latin America Genomic Biomarkers Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarkers Market Size (2017-2028)
10.2 Middle East & Africa Genomic Biomarkers Market Size by Type
10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Genomic Biomarkers Market Share by Type (2017-2028)
10.3 Middle East & Africa Genomic Biomarkers Market Size by Application
10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Genomic Biomarkers Market Share by Application (2017-2028)
10.4 Middle East & Africa Genomic Biomarkers Market Size by Country
10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Genomic Biomarkers Introduction
11.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Aepodia
11.3.1 Aepodia Company Details
11.3.2 Aepodia Business Overview
11.3.3 Aepodia Genomic Biomarkers Introduction
11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022)
11.3.5 Aepodia Recent Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Genomic Biomarkers Introduction
11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022)
11.4.5 Myriad Genetics Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Genomic Biomarkers Introduction
11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022)
11.5.5 Eurofins Scientific Recent Developments
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarkers Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022)
11.6.5 QIAGEN Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Genomic Health
11.8.1 Genomic Health Company Details
11.8.2 Genomic Health Business Overview
11.8.3 Genomic Health Genomic Biomarkers Introduction
11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022)
11.8.5 Genomic Health Recent Developments
11.9 Liquid Genomics
11.9.1 Liquid Genomics Company Details
11.9.2 Liquid Genomics Business Overview
11.9.3 Liquid Genomics Genomic Biomarkers Introduction
11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022)
11.9.5 Liquid Genomics Recent Developments
11.10 Epigenomics
11.10.1 Epigenomics Company Details
11.10.2 Epigenomics Business Overview
11.10.3 Epigenomics Genomic Biomarkers Introduction
11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022)
11.10.5 Epigenomics Recent Developments
11.11 AROS Applied Biotechnology
11.11.1 AROS Applied Biotechnology Company Details
11.11.2 AROS Applied Biotechnology Business Overview
11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022)
11.11.5 AROS Applied Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

本レポートと同じKEY WORD(biomarkers market)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る